Skip to main content
Advertisement
Advertisement

ONCY

ONCY logo

Oncolytics Biotech, Inc. Common Shares

0.68
USD
Sponsored
0.00
+0.60%
Sep 25, 15:59 UTC -4
Closed
exchange

After-Market

0.68

-0.01
-1.21%

Oncolytics Biotech, Inc. Common Shares Profile

About

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Info & Links

CEO

Jared Kelly

Headquarters

4350 Executive Drive, Suite 325
San Diego, CA 92121, CANADA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.oncolyticsbiotech.com

Auditor

Ernst & Young LLP

Share holders

45

Employees

29

Oncolytics Biotech, Inc. Common Shares Statistics

Valuation Measures

Market Capitalization2

86.07M

Enterprise Value

81.95M

Enterprise Value/EBITDA(ttm)

-2.18

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-2185.97%

Return on Invested Capital(ttm)

-11969.51%

Return on Assets(ttm)

-442.99%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-37.65M

Net Income Available to Common(ttm)

-37.46M

Diluted EPS(ttm)

-0.34

Share Statistics

Beta (5Y Monthly)

1.15

52-Week Change

-45.34%

S&P 500 52-Week Change

19.38%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

127.51M

Dividend Yield

0.00%

Float4

127.38M

% Held by Insiders

0.10%

% Held by Institutions

6.82%

Balance Sheet

Total Cash(mrq)

4.12M

Total Cash Per Share(mrq)

0.03

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.35%

Quick Ratio(mrq)

1.35%

Book Value Per Share(mrq)

-0.05

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.13

Free Cash Flow(ytd)

-15.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement